Literature DB >> 9458380

Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma.

I Bieche1, A Khodja, R Lidereau.   

Abstract

Cytogenetic and molecular studies have suggested that the 1p32-pter region might contain tumor-suppressor genes involved in the pathogenesis of breast cancer and other malignancies. Isolation of these genes could be facilitated by studying tumor cell lines with well-defined deleted regions. We examined deletions on chromosome 1p in 10 breast tumor cell lines, using a panel of 36 polymorphic markers located mainly in the 1p32-pter region, that comprised microsatellite, restriction fragment length polymorphism (RFLP) and variable number of tandem repeat (VNTR) markers. Two regions of interest were clearly identified: one (27 cM apart) is located at 1p32-p34 and reduces the smallest common deleted region (SCDR) to 8 cM if recorded the previous 1p LOH studies from primary breast tumors and the other (15 cM) is located at 1p36.2, within the 'consensus region of LOH' in neuroblastoma. These results show that the study of cell lines can refine SCDRs identified in primary tumors and can be used to identify putative homozygous deletions and to study the expression and structure alterations of candidate tumor-suppressor genes in these deleted regions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458380     DOI: 10.3892/or.5.1.267

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

Review 1.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

Review 2.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

3.  Genome-wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer.

Authors:  Zhihai Peng; Fang Zhang; Chongzhi Zhou; Yun Ling; Shaochun Bai; Wanqing Liu; Guoqiang Qiu; Lin He; Liwei Wang; Daoyan Wei; Edward Lin; Keping Xie
Journal:  Int J Gastrointest Cancer       Date:  2003

4.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

5.  The MYCN oncogene is a direct target of miR-34a.

Authors:  J S Wei; Y K Song; S Durinck; Q-R Chen; A T C Cheuk; P Tsang; Q Zhang; C J Thiele; A Slack; J Shohet; J Khan
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

6.  A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.

Authors:  Karl Vandepoele; Vanessa Andries; Nadine Van Roy; Katrien Staes; Jo Vandesompele; Geneviève Laureys; Els De Smet; Geert Berx; Frank Speleman; Frans van Roy
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.